Acellyrin

Acelyrin adds proof-of-concept TED data to recent readout pile, cementing challenge to Amgen
Fierce Biotech
Wed, 03/20/24 - 11:50 am
Acellyrin
thyroid eye disease
clinical trials
lonigutamab
Amgen